RAPH
Raphael Pharmaceutical Inc.
Key Financials
Operating Income
$-1245000
↑ 17.5%
Net Income
$-1279000
↑ 15.8%
EPS (Diluted)
$0.07
↓ 12.5%
Total Assets
$53000.00
↑ 96.3%
Cash & Equivalents
$19000.00
↓ 91.7%
Shareholders' Equity
$-1433000.00
↓ 93.1%
Operating Cash Flow
$-210000.00
↑ 60.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/14/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| 8-K | 3/24/2026 | View on SEC |
| 10-Q | 11/13/2025 | View on SEC |
| 3 | 9/8/2025 | View on SEC |
| 10-Q | 8/13/2025 | View on SEC |
| 8-K | 8/11/2025 | View on SEC |
| 8-K | 8/11/2025 | View on SEC |
| 10-Q | 5/15/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RAPH |
| Company Name | Raphael Pharmaceutical Inc. |
| CIK | 1415397 |
| Sector | Medicinal Chemicals & Botanical Products |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2833 |
| SIC Description | Medicinal Chemicals & Botanical Products |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 702-442-1166 |